Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

American Well Corporation Class A Common Stock (NY: AMWL )

12.16 +0.43 (+3.67%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about American Well Corporation Class A Common Stock

< Previous 1 2 3 4 Next >
Amwell® Announces Results for Fourth Quarter and Full Year 2024
From Amwell
Via GlobeNewswire
Amwell® to report fourth quarter and full year 2024 operating results
From Amwell
Via GlobeNewswire
Amwell® adds Vida to its clinical programs portfolio expanding access to obesity and diabetes care
Vida to offer cardiometabolic solutions including GLP-1s and other anti-obesity medications on the Amwell platform 
From Amwell
Via GlobeNewswire
Avel eCare Announces Acquisition of Amwell Psychiatric Care to Expand Telemedicine Services
Via ACCESSWIRE
Amwell® divests virtual psychiatric care business to Avel eCare in all-cash transaction
From Amwell
Via GlobeNewswire
Amwell CFO Mark Hirschhorn Expands Leadership Role
Seasoned leader assumes responsibility for operations and sales as COO 
From Amwell
Via GlobeNewswire
Amwell Announces Results for Third Quarter 2024
From Amwell
Via GlobeNewswire
Amwell Makes Grants to New Employees Under Inducement Plan
From Amwell
Via GlobeNewswire
Amwell to participate in upcoming investor conferences
From Amwell
Via GlobeNewswire
Amwell announces new chief financial officer
Industry veteran Mark Hirschhorn joins Amwell leadership team 
From Amwell
Via GlobeNewswire
Amwell to report third quarter 2024 operating results
From Amwell
Via GlobeNewswire
Amwell expands clinical programs portfolio to include Hello Heart cardiovascular health risk management solution
Hello Heart selects Amwell platform to extend its reach across patient populations 
From Amwell
Via GlobeNewswire
Amwell to Participate in Upcoming Investor Conferences
From Amwell
Via GlobeNewswire
Doximity: The 'Facebook for Doctors' Surges After Earnings Beat
Doximity Inc. (NYSE: DOCS) is a digital professional medical networking platform that is a cross between LinkedIn and Meta Platforms Inc. 
Via MarketBeat
Amwell Announces Results for Second Quarter 2024
From Amwell
Via GlobeNewswire
Can the New CEO Revive This Struggling Telehealth Stock?
Virtual healthcare provider Teladoc Health Inc. (NYSE: TDOC) stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023 
Via MarketBeat
Topics Earnings
Exposures Financial
Amwell® to Report Second Quarter 2024 Operating Results
From Amwell
Via GlobeNewswire
Amwell Announces Reverse Stock Split
From Amwell
Via GlobeNewswire
Amwell Announces Appointment of Ricky Goldwasser to its Board of Directors
From Amwell
Via GlobeNewswire
Amwell Co-Founder Roy Schoenberg Becomes Executive Vice Chairman of the Board
Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility 
From Amwell
Via GlobeNewswire
Hims & Hers Health Soars on Generic GLP-1 Rollout Plans
Him & Hers Health Inc. (NYSE: HIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments 
Via MarketBeat
Doximity is the Facebook and LinkedIn of the Medical Community
Doximity stock is surging as analysts and investors are taking note of the cloud-based digital platform's strong revenue and earnings growth 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference
Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility 
From Amwell
Via GlobeNewswire
AMWELL ANNOUNCES RESULTS FOR FIRST QUARTER 2024
From Amwell
Via GlobeNewswire
Amwell Releases 2024 Corporate Responsibility Report
Report demonstrates company progress toward enabling digital healthcare with purpose 
From Amwell
Via GlobeNewswire
Amwell to Participate in Upcoming Investor Conference
From Amwell
Via GlobeNewswire
Amwell® to Report First Quarter 2024 Operating Results May 1
From Amwell
Via GlobeNewswire
Amwell Receives Continued Listing Standard Notice From NYSE
Amwell’s Class A Common Stock continues to trade on the NYSE 
From Amwell
Via GlobeNewswire
LifeMD Shares Come Back to Life on GLP-1 Business Growth
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024 
Via MarketBeat
Power of Amwell Hybrid Care Solutions to be Highlighted at HIMSS 2024
Amwell clients to present on automated care, Converge platform integration 
From Amwell
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.